RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$122.5B
P/E ratio
33.8x
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and cash equivalents2434754895696257151,1841,6652,6503,1095,9886,79510,50410,369
Marketable securities788494832896762328251423518699671730275849
Accounts receivable, net1318314386761782012814106348851,1371,4421,563
Inventories-1123014315778112124168281353461739
Prepaid expenses and other current assets13152524535171166141214308546554624
Total current assets1,0571,3311,5901,5891,5471,4071,8322,6493,8434,8238,1339,56113,23514,144
Property and equipment, net----------9591,0941,1081,159
Goodwill2631313140505050501,0001,0001,0001,1001,100
Other intangible assets, net---------400400400604840
Deferred tax assets---------1,1918839351,2471,812
Operating lease assets----------326330347294
Other assets1711102371284115849111522895
Long-term marketable securities-------------2,498
Total assets1,7252,2042,7592,3192,3352,4992,8973,5466,2468,31811,75213,43318,15122,730
Other assets1711102371284115849111522895
Total assets1,7252,2042,7592,3192,3352,4992,8973,5466,2468,31811,75213,43318,15122,730
Accounts payable3675101497175617411188155195304365
Accrued expenses1342522652712103063154446041,1171,4051,6792,1272,655
Other current liabilities6-2025514112741130317268312527
Total current liabilities4753924333983685067938071,1201,3351,8782,1422,7423,547
Long-term finance lease liabilities---------539539510431376
Long-term operating lease liabilities----------350377380349
Other long-term liabilities-7141222321022626183108117686878
Total liabilities1,2211,2391,5259631,2381,4051,5591,5041,8112,2333,0653,3334,2385,150
Commitments and contingencies--------------
Preferred Stock, Value, Issued--------------
Common Stock, Value, Issued22222223333333
Additional paid-in capital3,9474,2014,5195,3215,7776,1986,5077,1577,4217,9387,8946,8817,3877,450
Accumulated other comprehensive (loss) income-1-1-1-01221-121-2-68161-14
Retained earnings-3,444-3,415-3,522-3,967-4,705-5,262-5,374-5,120-2,989-1,8538593,2016,52310,142
Total shareholders’ equity5049281,1961,3561,0961,0941,3382,0424,4356,0858,68710,10013,91317,580
Total liabilities and shareholders’ equity1,7252,2042,7592,3192,3352,4992,8973,5466,2468,31811,75213,43318,15122,730